›
^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersTEST:AnchorAIM® 72 gene detection for individualized treatment of solid tumors
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
AnchorDxType:
Laboratory Developed Test
Related tests:
AnchorAIM ® solid tumor personalized treatment 72 gene detection, for cancer patients, using high-throughput sequencing technology to accurately detect the most relevant gene mutations related to tumor treatment and prognosis, to provide the most clinically valuable genes for tumor targeted therapy information.
Cancer:
Solid Tumor
Gene:
AKT1 (V-akt murine thymoma viral oncogene homolog 1), ALK (Anaplastic lymphoma kinase), APC (APC Regulator Of WNT Signaling Pathway), ATM (ATM serine/threonine kinase), BRAF (B-raf proto-oncogene), BRCA1 (Breast cancer 1, early onset)
See More ...
AKT1 (V-akt murine thymoma viral oncogene homolog 1), ALK (Anaplastic lymphoma kinase), APC (APC Regulator Of WNT Signaling Pathway), ATM (ATM serine/threonine kinase), BRAF (B-raf proto-oncogene), BRCA1 (Breast cancer 1, early onset), BRCA2 (Breast cancer 2, early onset), CCNE1 (Cyclin E1), CDH1 (Cadherin 1), CDK4 (Cyclin-dependent kinase 4), CDK6 (Cyclin-dependent kinase 6), CDKN2A (Cyclin Dependent Kinase Inhibitor 2A), CDKN2B (Cyclin Dependent Kinase Inhibitor 2B), CSF1R (Colony stimulating factor 1 receptor), CTNNB1 (Catenin (cadherin-associated protein), beta 1), CYP2D6 (Cytochrome P450 Family 2 Subfamily D Member 6), DDR2 (Discoidin domain receptor 2), DPYD (Dihydropyrimidine Dehydrogenase), EGFR (Epidermal growth factor receptor), ERBB3 (V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 3), ERBB4 (erb-b2 receptor tyrosine kinase 4), EWSR1 (EWS RNA Binding Protein 1), EZH2 (Enhancer of zeste 2 polycomb repressive complex 2 subunit), FBXW7 (F-Box And WD Repeat Domain Containing 7), FGFR1 (Fibroblast growth factor receptor 1), FGFR2 (Fibroblast growth factor receptor 2), FGFR3 (Fibroblast growth factor receptor 3), GNA11 (G Protein Subunit Alpha 11), GNAQ (G Protein Subunit Alpha Q), GNAS (GNAS Complex Locus), HER-2 (Human epidermal growth factor receptor 2), HRAS (Harvey rat sarcoma viral oncogene homolog), IDH1 (Isocitrate dehydrogenase (NADP(+)) 1), IDH2 (Isocitrate Dehydrogenase (NADP(+)) 2), JAK1 (Janus Kinase 1), JAK2 (Janus kinase 2), KDR (Kinase insert domain receptor), KIT (KIT proto-oncogene, receptor tyrosine kinase), KRAS (KRAS proto-oncogene GTPase), MAP2K1 (Mitogen-activated protein kinase kinase 1), MAP2K2 (Mitogen-activated protein kinase kinase 2), MET (MET proto-oncogene, receptor tyrosine kinase), MLH1 (MutL homolog 1), MSH6 (MutS homolog 6), MYC (V-myc avian myelocytomatosis viral oncogene homolog), NF1 (Neurofibromin 1), NF2 (Neurofibromin 2), NOTCH1 (Notch 1), NRAS (Neuroblastoma RAS viral oncogene homolog), PDGFRA (Platelet Derived Growth Factor Receptor Alpha), PIK3CA (Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), PIK3R1 (Phosphoinositide-3-Kinase Regulatory Subunit 1), PMS2 (PMS1 protein homolog 2), POLD1 (DNA Polymerase Delta 1), PTCH1 (Patched 1), PTEN (Phosphatase and tensin homolog), PTPN11 (Protein Tyrosine Phosphatase Non-Receptor Type 11), RAF1 (Raf-1 Proto-Oncogene Serine/Threonine Kinase), RET (Ret Proto-Oncogene), ROS1 (Proto-Oncogene Tyrosine-Protein Kinase ROS), SMAD4 (SMAD family member 4), SMO (Smoothened Frizzled Class Receptor), STK11 (Serine/threonine kinase 11), TERT (Telomerase Reverse Transcriptase), TP53 (Tumor protein P53), TPMT (Thiopurine S-Methyltransferase), TSC1 (TSC complex subunit 1), TSC2 (TSC complex subunit 2), UGT1A1 (UDP glucuronosyltransferase family 1 member A1), mTOR (Mechanistic target of rapamycin kinase)
